Apr 5 |
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
|
Apr 1 |
IDEAYA Biosciences to Participate in Upcoming April 2024 Investor Relations Event
|
Mar 27 |
TipRanks’ ‘Perfect 10’ List: These 3 Top-Scoring Stocks Are Sending a Bullish Signal
|
Mar 12 |
Ideaya inks clinical trial pact with Merck
|
Mar 12 |
IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer
|
Mar 8 |
IDEAYA a new Buy at BTIG on underappreciated pipeline
|
Mar 4 |
IDEAYA Biosciences to Participate in Upcoming March 2024 Investor Relations Events
|
Feb 23 |
IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Analysts Are Pretty Bullish On The Stock After Recent Results
|
Feb 20 |
Recap: IDEAYA Biosciences Q4 Earnings
|
Feb 20 |
IDEAYA Biosciences GAAP EPS of -$0.52, revenue of $3.9M
|